Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicki Niemann
Correction To: Treatment of Tardive Dyskinesia: A General Overview With Focus on the Vesicular Monoamine Transporter 2 Inhibitors
Drugs
Pharmacology
Related publications
Ephedrine Decreases Vesicular Monoamine Transporter-2 Function
Synapse
Molecular Neuroscience
Cellular
The Vesicular Monoamine Transporter 2: An Underexplored Pharmacological Target
Neurochemistry International
Molecular Neuroscience
Cell Biology
Cellular
GZ-793A, a Lobelane Analog, Interacts With the Vesicular Monoamine Transporter-2 to Inhibit the Effect of Methamphetamine
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular
Pyrrolidine Analogs of GZ-793A: Synthesis and Evaluation as Inhibitors of the Vesicular Monoamine Transporter-2 (VMAT2)
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Genetic Variation in the Vesicular Monoamine Transporter
Journal of Head Trauma Rehabilitation
Physical Therapy
Sports Therapy
Neurology
Rehabilitation
Treatment of Tardive Dyskinesia With Choline and Tetrabenazine.
Postgraduate Medical Journal
Medicine
Lobelane Analogues as Novel Ligands for the Vesicular Monoamine Transporter-2
Bioorganic and Medicinal Chemistry
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Preclinical Efficacy of Novel Vesicular Monoamine Transporter 2 Inhibitors as Antagonists of D-Methamphetamine Self-Administration in Rats
Journal of Alcoholism & Drug Dependence
Therapeutic Doses of Amphetamine and Methylphenidate Selectively Redistribute the Vesicular Monoamine Transporter-2
European Journal of Pharmacology
Pharmacology
